SCHEMBL10060182

SCHEMBL10060182

Cc1ccc2c(ccc3cc(B4OC(C)(C)C(C)(C)O4)ccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 12/20 0.46
▸ LIPG Q9Y5X9 12/20 0.46
▸ CSF1R P07333 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CYP1A2 P05177 3/20 0.39
▸ CYP2A6 P11509 2/20 0.39
▸ HIF1A Q16665 1/20 0.38
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13331256 0.98 LPL (0.45) LPLLIPGCSF1RIRAK4KDM4E
SCHEMBL13331252 0.92 LPL (0.43) LPLLIPGCSF1RIRAK4KDM4E
SCHEMBL12654466 0.91 LPL (0.54) LPLLIPGCSF1RIRAK4CYP1A2
SCHEMBL6126262 0.91 LPL (0.53) LPLLIPGCSF1RIRAK4CA1
SCHEMBL31243812 0.90 LPL (0.53) LPLLIPGCSF1RIRAK4CYP1A2
SCHEMBL1627177 0.90 LPL (0.51) LPLLIPGCSF1RIRAK4CA1
SCHEMBL11959548 0.88 LPL (0.51) LPLLIPGCSF1RIRAK4CYP1A2
SCHEMBL27026513 0.88 LIPG (0.64) LPLLIPGCSF1RIRAK4KDM4E
SCHEMBL13330818 0.85 LPL (0.45) LPLLIPGCSF1RIRAK4CYP1A2
SCHEMBL1628014 0.85 LPL (0.47) LPLLIPGCSF1RIRAK4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023427-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2024-01-18 — — US disclosed
US-20240023427-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2024-01-18 — — US disclosed
US-8729541-B2 Phenanthrene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-05-20 — — US disclosed
US-8729541-B2 Phenanthrene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-05-20 — — US disclosed
US-20130207096-A1 PHENANTHRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-15 — — US disclosed
US-20130207096-A1 PHENANTHRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-15 — — US disclosed
WO-2012060307-A1 PHENANTHRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023427-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CCNL2, AHR, ARNT LPL 2919/4885LIPG 3077/4885CSF1R 2504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback